Preliminary report on the use of danazol in the treatment of endometrial adenomatous hyperplasia
article
OA: bronze
CC0
⤵ 8 in-corpus citations
AI-generated summary
Danazol treatment for 3 months resulted in symptom resolution and regression of adenomatous hyperplasia in five patients, suggesting its potential for treating this condition.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Since the authors recently reported that danazol inhibits the growth of human endometrial cancer cells in vitro, a clinical trial was initiated to examine whether danazol can regress adenomatous hyperplasia, a precursor of endometrial adenocarcinoma. Danazol was used for 3 months in the treatment of five patients with a history of hypermenorrhea and irregular uterine bleeding. Within a 9-month follow-up period, all patients were symptom-free, and none of the specimens obtained by endometrial biopsy showed the presence of adenomatous hyperplasia. These findings suggest that danazol has a potential application in the treatment of patients with endometrial adenomatous hyperplasia. A possible mechanism of action of the compound in adenomatous hyperplasia is also discussed.
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (8)
- Danazol binds to progesterone receptors and inhibits the growth of human endometrial cancer cells in vitro via openalex
- Danazol has progestin-like actions on the human endometrium via openalex
- Growth inhibition by danazol in a human endometrial cancer cell line with estrogen-independent progesterone receptors via openalex
- Preliminary report on postmenopausal endometrial hyperplasia treatment with Danazol: histological and endocrinological aspects. via openalex
- Short‐term effects of danazol and medroxyprogesterone acetate on cytosol and nuclear estrogen and progestin receptors, 17β‐hydroxysteroid dehydrogenase activity, histopathology, and ultrastructure of human endometrial adenocarcinoma via openalex
- Short‐term effects of danazol on endometrial histology via openalex
- doi:10.1002/1097-0142(19880401)61:7<1312::aid-cncr2820610706>3.0.co;2-k via openalex
- doi:10.1016/0002-9378(81)90611-6 via openalex
Cited by (8)
- Molecular profiling of human endometrium and endometriosis 2010
- Preventive effects of danazol on endometrial carcinogenesis in mice 2000
- Danazol enhances Fas-mediated apoptosis in human endometrial epithelial cells within normal physiology 1998
- Postmenopausal endometrial hyperplasia: role of danazol therapy 1994
- Suppression of the development of uterine adenomyosis by danazol treatment in mice 1992
- Endometrial Effects of Danazol in Perimenopausal Abnormal Bleeding 1991
- Preinvasive Lesions of the Endometrium 1991
- Effects of danazol, gonadotropin-releasing hormone agonist, and a combination of danazol and gonadotropin-releasing hormone agonist on experimental endometriosis 1990
Source provenance
- openalex
- last seen: 2026-05-11T05:56:47.744056+00:00
License: CC0
· commercial use OK